[Elsevier] Efficacy and safety of branebrutinib (BMS-986195), an irreversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2a, randomised, double-blind, placebo-controlled study |
|
This post will be closed automatically in 2026-11-06 04:35
Reward30points
|
| |
10
Enhanced particle interlocking and interface design in dry-processed polymer-in-ceramic composite electrolytes with multifunctional silane
10
Intraoperative Complications During Benign Esophageal Surgery
10
Green synthesis of ZnO using olives leaf extract: Parameters optimization and its application on adsorption and photocatalytic degradation of direct red 80
10
Plasma perfluoroalkyl substance exposure and incidence risk of breast cancer: A case-cohort study in the Dongfeng-Tongji cohort
10
Altmetrics
